DGAP-News: Medios AG / Key word(s): Expansion
Corporate News Medios AG acquires additional cleanroom capacities and starts announced expansion of its manufacturing capacities for personalized medicine Berlin, September 25, 2017 - Medios AG, one of the leading competence partners and solution providers for specialty pharmaceuticals in Germany, acquires the Berlin-based manufacturing premises of PGD Profusio Berlin GesundHeits GmbH Deutschland in order to expand its cleanroom capacities. Thus, a first step in the expansion of the manufacturing capacities for personalized medicine, which has already been announced by Medios AG, is being made. Manfred Schneider, CEO of Medios AG: "With the additional cleanroom capacities, we can expand our manufacturing capacities for personalized medicine soon and further diversify our indication areas. We are confident that the production in the new premises will already be profitable in the coming year." In addition to the newly acquired cleanroom capacities, Medios AG will once again expand its capacities as planned as of 2019 with the completition of its new building at the future location in Berlin-Charlottenburg. About Medios With our subsidiaries Medios Pharma, Medios Manufaktur and Medios Digital, we connect individual market players to form cooperating partners. Our goal is to provide partners and customers with integrated solutions along the value chain, ensuring optimal patient care. Disclaimer
25.09.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Medios AG |
Friedrichstraße 113a | |
10117 Berlin | |
Germany | |
Phone: | +49 30 232 566 - 800 |
Fax: | 030 / 8321 8377 |
E-mail: | ir@medios.ag |
Internet: | www.medios.ag |
ISIN: | DE000A1MMCC8 |
WKN: | A1MMCC |
Listed: | Regulated Market in Frankfurt (General Standard), Hamburg; Regulated Unofficial Market in Dusseldorf |
End of News | DGAP News Service |